Elsevier

Human Pathology

Volume 28, Issue 7, July 1997, Pages 801-808
Human Pathology

Original contribution
Human herpesvirus-8-associated body cavity-based lymphoma in human immunodeficiency virus-infected patients: A unique B-cell neoplasm

https://doi.org/10.1016/S0046-8177(97)90153-2Get rights and content

Abstract

Human immunodeficiency virus (HIV)-related body cavity-based lymphomas (BCBLs) are known to exhibit unusual clinical, immunophenotypic, and genotypic features, and have recently been found to harbor DNA sequences of a new human herpesvirus, designated Kaposi's sarcoma-associated herpesvirus (KSHV) or human herpesvirus 8 (HHV-8). The authors have encountered eight cases of HHV-8-associated BCBL in HIV-infected patients. A literature search revealed an additional 50 reported cases of HIV-related BCBL, as well as reports of several other disorders associated with HHV-8 DNA. Comprehensive analysis of the clinical and pathobiological features of all 58 known cases of HIV-related BCBL shows it to be a unique B-cell neoplasm with a strong propensity for body-cavity involvement without mass lesions and with little or no dissemination, poor prognosis, high grade usually immunoblastic morphology, late B-cell phenotype and genotype, no associated c-myc gene rearrangement, frequent presence of Epstein-Barr virus (EBV) genome, and uniform association with HHV-8 DNA. Considering these features in the context of other disorders associated with HHV-8 DNA, HHV-8 appears to play a causal role in BCBL, possibly in concert with EBV, and may induce this lymphoma through dysregulation of cytokines, particularly interleukin-6, or infection of an unusual B-cell subset. The characteristics of HHV-8-associated BCBL suggest a possible role for antiherpes or anticytokine agents in the treatment of this lymphoma.

References (47)

  • JL Ziegler et al.

    Non-Hodgkin's lymphoma in 90 homosexual men: Relation to generalized lymphadenopathy and the acquired immunodeficiency syndrome

    N Engl J Med

    (1984)
  • AE Walts et al.

    Diagnosis of malignant lymphoma in effusions from patients with AIDS by gene rearrangement

    Am J Clin Pathol

    (1990)
  • DS Karcher et al.

    Body cavity-based non-Hodgkin's lymphoma (NHL) in HIV-infected patients: B-cell lymphoma with unusual clinical, immunophenotypic, and genotypic features

    Lab Invest

    (1992)
  • I Green et al.

    Primary lymphomatous effusions in AIDS: A morphological, immunophenotypic, and molecular study

    Mod Pathol

    (1995)
  • Y Chang et al.

    Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma

    Science

    (1994)
  • E Cesarman et al.

    Kaposi's sarcoma-associated herpervirus-like DNA sequences in AIDS-related body-cavity-based lymphomas

    N Engl J Med

    (1995)
  • DS Karcher et al.

    Herpes-like DNA sequences, AIDS-related tumors, and Castleman's disease

    N Engl J Med

    (1995)
  • BJ Nickoloff et al.

    Charting a new course through the chaos of KS (Kaposi's sarcoma)

    Am J Pathol

    (1996)
  • PS Moore et al.

    Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma in patients with and those without HIV infection

    N Engl J Med

    (1995)
  • DP McDonagh et al.

    Detection of Kaposi's sarcoma-associated herpesvirus-like DNA sequences in angiosarcoma

    Mod Pathol

    (1996)
  • N Dupin et al.

    Herpes-like DNA sequences, AIDS-related tumors, and Castleman's disease

    (letter) N Engl J Med

    (1995)
  • A Chadburn et al.

    Kaposi's sarcoma-associated herpesvirus sequences in non-HIV-associated benign lymphoproliferative lesions

    Mod Pathol

    (1996)
  • E Cesarman et al.

    Response to letter

    N Engl J Med

    (1996)
  • Cited by (66)

    • Lymphoid Lesions of the Lung

      2018, Pulmonary Pathology: A Volume in the Series: Foundations in Diagnostic Pathology
    • Extracavity primary effusion lymphoma presenting in a lymph node without lymphomatous effusions

      2015, Human Pathology: Case Reports
      Citation Excerpt :

      It can also occur as a nodal extracavitary lymphoma, as in the current case [9,16]. Although EPEL develops primarily, although not exclusively, in patients with AIDS or severe immunodeficiency [2,8], the diagnosis of EPEL warranted HIV testing, which was positive in this case. PEL has an extremely unfavorable prognosis with a median overall survival time of less than six months [17].

    • Lymphoproliferative disorder in pleural effusion in a subject with past asbestos exposure

      2015, Respiratory Medicine Case Reports
      Citation Excerpt :

      The 2001 World Health Organization classification defines PEL as a disease entity representing a part of diffuse large B-cell lymphoma [1]. PEL is commonly associated with HHV8 infection [2]; however, PEL-like disease processes have recently been reported in HHV8-negative patients. Those cases are considered a rare disease entity called HHV8-unrelated PEL-like lymphoma [3].

    • Complete response to EPOCH in a patient with HIV and extracavitary primary effusion lymphoma involving the colon: A case report and review of literature

      2012, Clinical Lymphoma, Myeloma and Leukemia
      Citation Excerpt :

      Karcher et al described the distinctive characteristics of PEL, including the initial presentation as a lymphomatous effusion in the absence of a contiguous tumor mass.1 Its epidemiologic features are similar to Kaposi's sarcoma (ie., occurring primarily in men, most of whom are HIV+ with homosexuality as a risk factor) 1,7 Morphologically, PEL bridges immunoblastic anaplastic features and displays a degree of plasma cell differentiation as shown by immunohistochemical positivity for CD138/syndecan-1, a plasma cell–associated antigen.8,10 Distinguishing PEL from other NHLs involving body cavities initially involves clinical and basic morphologic assessment and is enhanced by immunocytochemical and/or flow cytometric demonstration of positivity for HHV-8 and negativity for most B-cell–associated antigens.9

    • Update on pulmonary and pleural lymphoproliferative disorders

      2008, Diagnostic Histopathology
      Citation Excerpt :

      PEL is considered a post-germinal centre B-cell lymphoma with plasmacytic differentiation which often develops in the setting of immunosuppression due to the oncogenic effects of latent infection with HHV-8.166,167 Co-infection with EBV occurs in about 80% of cases and likely contributes to neoplastic transformation.159,160,176,183 More recently, PEL has been recognized as part of the spectrum of diffuse large B-cell lymphomas with plasmablastic differentiation.189

    • Lymphoid Lesions of the Lung

      2008, Pulmonary Pathology: a Volume in the Series Foundations in Diagnostic Pathology
    View all citing articles on Scopus
    View full text